Evidence map›Paper›PMID 41073869›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Extending the Potential of Digital Droplet PCR by Expressing Amplified Genes and Assaying Their Phenotype.

Janine Kehrli, Radi Khodr, Michael Ryckelynck

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Janine KehrliUniversité de Strasbourg, CNRS, Architecture et Réactivité de l'ARN, UPR9002, Strasbourg, France.
Radi KhodrUniversité de Strasbourg, CNRS, Architecture et Réactivité de l'ARN, UPR9002, Strasbourg, France.
Michael RyckelynckUniversité de Strasbourg, CNRS, Architecture et Réactivité de l'ARN, UPR9002, Strasbourg, France. m.ryckelynck@unistra.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Besides its key role in genetic information storage, DNA is also highly relevant to be used as an amplifiable and readable biomarker for plenty of applications including diagnostics, sterility, and quality controls. To this end, several molecular analytical methods emerged over the past decades to specifically detect and quantify DNA sequences from different sample origins. Significant gain in sensitivity was reached with the advent of digital droplet PCR (ddPCR), while also overcoming many important limitations of quantitative PCR. In ddPCR, DNA templates are typically isolated in water-in-oil droplets containing a PCR amplification mixture supplemented with a fluorogenic reporter. Whereas the analytical process usually ends with the counting of the fraction of fluorescent droplets in which PCR amplification took place, in some cases these droplets can be the starting point of more complex analytical pipelines. This is typically the case of the microfluidic-assisted in vitro compartmentalization technology introduced by our team and routinely used to perform in vitro functional screenings and directed evolution experiments. In this chapter, we present this technology in which DNA templates are first amplified by ddPCR, prior to being in vitro expressed as RNA or protein within these droplets. Finally, the phenotype of each gene is analyzed using a fluorescence-based assay and the droplets sorted accordingly.

Indexed as

Polymerase Chain ReactionDNAHumansMicrofluidic Analytical TechniquesPhenotypeDNADirected evolutionDNA quantificationDroplet digital PCRDroplet fusionDroplet microfluidicsDroplet sortingIn vitro gene expressionGene expression (GEX)

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.